Article Details

Endeavor Bio adds $101M to test ex-Eli Lilly, Roche drug in cancer & lung fibrosis - MedCity News

Retrieved on: 2022-02-08 00:26:23

Tags for this article:

Click the tags to see associated articles and topics

Endeavor Bio adds $101M to test ex-Eli Lilly, Roche drug in cancer & lung fibrosis - MedCity News. View article details on hiswai:

Excerpt

That biotech aimed to develop it as a treatment for basal cell carcinoma. Taladegib and other assets went to Roche in 2017 when the Swiss pharma giant ...

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up